Company News
Sudarshan Pharma Acquires 9.5% MedTherapy Stake
Sudarshan Pharma board approved acquiring 9.50% stake in US-based MedTherapy Biotechnology Inc. for market expansion.
Promoters Hemal Mehta and Sachin Mehta will each acquire 1.50% stake in the cancer
